<DOC>
	<DOCNO>NCT01520298</DOCNO>
	<brief_summary>This research study prospective , randomize , blind , placebo control trial evaluating benefit IV acetaminophen ( Ofirmev™ ) adjuvant analgesia geriatric hip fracture patient . IV acetaminophen receive FDA approval . IV acetaminophen liver toxicity oral acetaminophen . No oral acetaminophen administer . All patient diagnose hip fracture age least 65 year expect undergo surgical intervention eligible participate . Hip fracture affect great 300,000 geriatric patient annually , represent second leading cause hospitalization patient population . Pain control patient often problematic due co-morbidities change pharmacokinetic pharmacodynamic profile . Subjects may receive normal DVT prophylactic treatment post-op .</brief_summary>
	<brief_title>Intravenous Acetaminophen Adjuvant Therapy Pain Control Geriatric Hip Fracture Patients</brief_title>
	<detailed_description>Approximately 46 subject enrol LGH . Subjects randomize 1:1 receive either IV acetaminophen 1000 mg q6 hour ( FDA recommend dose ) IV placebo . While receive study drug/placebo subject 's blood pressure , heart rate , respiratory rate , &amp; pain intensity monitor . Additional pain med give need . Study treatment continue subject take operating room ; time intervention discontinue pain medication provide . Participation study end time discharge hospital . Researchers expect 33 % decrease opioid use subject randomized treatment group .</detailed_description>
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Hip Fractures</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>All patient age least 65 year diagnosis hip fracture surgical intervention expect Patients follow surgeon ( David Hughes MD , Gerald Rothacker MD , Frank Essis MD , James Carson MD , Michael Gish MD , Vincent Battista MD ) Documented drug alcohol addiction abuse Documented serum sodium level &gt; 145 mmol/L Documented serum chloride level &gt; 107 mmol/L Impaired liver function define ALT AST &gt; 3 time upper limit normal , ChildPugh class C , patient document active liver disease Known allergy intolerance acetaminophen Weight ≤ 50 kg Creatinine clearance ( CrCl ) ≤ 30 ml/min determine CockcroftGault equation Documented dementia Acetaminophen ( &gt; 650 mg ) opioid ( &gt; 7 mg IV morphine equivalence ) use within previous 24 hour Documented chronic opioid use</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>